Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial
Bo Xu, Shengxian Tu, Lei Song, Zening Jin, Bo Yu, Guosheng Fu, Yujie Zhou, Jianan Wang, Yundai Chen, Jun Pu, Lianglong Chen, Xinkai Qu, Junqing Yang, Xuebo Liu, Lijun Guo, Chengxing Shen, Yao‐Jun Zhang, Qi Zhang, Hongwei Pan, Xiaogang Fu, Jian Liu, Yanyan Zhao, Javier Escaned, Yang Wang, William F. Fearon, Kefei Dou, Ajay J. Kirtane, Yongjian Wu, Patrick W. Serruys, Weixian Yang, William Wijns, Changdong Guan, Martin B. Leon, Shubin Qiao, Gregg W. Stone (2021). Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial. The Lancet, 398(10317), pp. 2149-2159, DOI: 10.1016/s0140-6736(21)02248-0.
